Search
forResearch 10 of 232
- Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Discoid Lupus Erythematosus
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
- Genetic Basis of Alopecia Areata
- Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions
- Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case–Control Study
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →